<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-24969" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Streptococcal Meningitis</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Ma&#x00144;dziuk</surname>
            <given-names>Joanna</given-names>
          </name>
          <aff>Medical University of Warsaw</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Kuchar</surname>
            <given-names>Ernest P.</given-names>
          </name>
          <aff>Warsaw University of Medicine</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Joanna Ma&#x00144;dziuk declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Ernest Kuchar declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>10</day>
          <month>4</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-24969.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Streptococcal meningitis is an acute, purulent inflammation of the membranes surrounding the brain and spinal cord caused by bacteria from the Streptococci species. This condition requires prompt diagnosis and treatment to avoid the high morbidity and morbidity associated with its complications. This activity reviews the evaluation and treatment of Streptococcal meningitis and highlights the role of the interprofessional team in managing patients with this condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Summarize the etiology of Streptococcal meningitis.</p></list-item><list-item><p>Describe the typical history and physical of the patients with Streptococcal meningitis.</p></list-item><list-item><p>Review the management options available for streptococcal meningitis.</p></list-item><list-item><p>Explain the importance of improving care coordination among the interprofessional team to enhance the delivery of care for patients with streptococcal meningitis.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=24969&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=24969">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-24969.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Streptococcal meningitis is an acute inflammation of the membranes surrounding the brain and spinal cord caused by bacteria from the streptococcal species. Bacterial meningitis is a severe and life-threatening infection that may lead to death, especially when treatment initiation is overdue. Despite progress in diagnostic methods and treatment as well as the implementation of national immunization programs, bacterial meningitis is still one of the most burdening infectious diseases worldwide.</p>
      </sec>
      <sec id="article-24969.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Numerous <italic toggle="yes">Streptococcus</italic> bacteria can cause meningitis. The most significant one is <italic toggle="yes">Streptococcus pneumoniae</italic>, probably the leading etiologic agent of meningitis worldwide, both in adults and children. In the beta-hemolytic group, the most notable is group B <italic toggle="yes">Streptococcus</italic> (GBS) &#x02013; the most common cause of meningitis in neonates and young infants. Other Streptococci, i.e., belonging to the<italic toggle="yes"> S. viridans</italic> group or group A are very rarely causative pathogens of meningitis in adults or children.</p>
      </sec>
      <sec id="article-24969.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>The etiologic agents causing streptococcal meningitis vary by age group. <italic toggle="yes">Streptococcus pneumoniae</italic> remains the most common etiologic agent of bacterial meningitis in children above one month and adults of all ages. In the U.S., the incidence of pneumococcal meningitis decreased from 0.8 per 100000 people in 1997 to 0.3 per 100000 people in 2010 (PCV 7 was introduced in 2000).<xref ref-type="bibr" rid="article-24969.r1">[1]</xref>
<italic toggle="yes">S. pneumoniae</italic> infection is also the most common cause of bacterial meningitis in children, ranging from 22.5% in Europe to 41.1% in Africa.<xref ref-type="bibr" rid="article-24969.r2">[2]</xref> In the developing world, invasive pneumococcal disease (IPD) is a significant cause of morbidity and mortality, with up to 1.0 million deaths per year in children less than five years old.<xref ref-type="bibr" rid="article-24969.r3">[3]</xref></p>
        <p>In neonates, <italic toggle="yes">S. agalactiae</italic> is one of the leading pathogens responsible for meningitis. In the U.S., from 2006&#x000a0;to 2015, early-onset disease (onset at 0&#x000a0;to 6 days of life, EOD) incidence decreased from 0.37 to 0.23 per 1000 live births, mainly due to intrapartum antibiotic prophylaxis. Late-onset disease (LOD) rates were stable in those years.<xref ref-type="bibr" rid="article-24969.r4">[4]</xref> The global incidence of invasive GBS disease in infants is 0.49 per 1000 live births, with the highest numbers in Africa.<xref ref-type="bibr" rid="article-24969.r5">[5]</xref> Other groups of streptococci rarely cause meningitis. <italic toggle="yes">S. viridans</italic> accounts for 0.3% to 3.0% of cases of bacterial meningitis in adults and 1% in children.<xref ref-type="bibr" rid="article-24969.r6">[6]</xref> Group A streptococcal meningitis was diagnosed in 2% of the cases of community-acquired bacterial meningitis.<xref ref-type="bibr" rid="article-24969.r7">[7]</xref></p>
      </sec>
      <sec id="article-24969.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Meningitis occurs when bacteria enter the bloodstream and then cross the blood-brain barrier or through direct contact of meninges with the skin or nasal cavity. The most frequent focus of the infection is the nasopharynx colonized by <italic toggle="yes">S. pneumoniae</italic> that evades the host immune system. During IPD, the bloodstream becomes invaded, and complement and coagulation systems are activated. Inflammatory mediators are released massively, which makes it easier for the bacteria to cross the blood-brain barrier. Inflammation is responsible for all the typical findings of bacterial meningitis, i.e., CSF pleocytosis.</p>
      </sec>
      <sec id="article-24969.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Symptoms of bacterial meningitis, including Streptococcal, can develop either suddenly or over a few days. Typically they are present 3 to 7 days after exposure. There are no specific symptoms that allow recognition of causative agents of bacterial meningitis based solely on history taking and examination.</p>
        <p>
<bold>Adults</bold>
</p>
        <p>The classic triad of diagnostic symptoms of meningitis in adults includes fever, nuchal rigidity, and altered mental status; however, only 44% of adult patients with bacterial meningitis present with all three symptoms.<xref ref-type="bibr" rid="article-24969.r8">[8]</xref> In the same study, nearly all patients had a minimum of two out of four symptoms among headache, fever, neck stiffness, and altered mental status.<xref ref-type="bibr" rid="article-24969.r8">[8]</xref> Other complaints typically reported by patients are severe headache, intensified by head movements, nausea, vomiting, and photophobia. In the study by Lucht accuracy of clinical examination for the diagnosis of meningitis in adults was reviewed. Sensitivity for clinical signs like headache, vomiting, or fever was less than 30%, and for nuchal rigidity, 45%.<xref ref-type="bibr" rid="article-24969.r9">[9]</xref> The study also showed that if two out of four signs among headache, fever, altered mental status, and neck stiffness are absent, the diagnosis of meningitis is extremely unlikely (with a negative predictive value of 95%). A Danish study enrolled adults with pneumococcal meningitis. On admission, researchers observed fever and an altered mental status in almost all cases. Back rigidity, headache, and convulsions were found less commonly (57%, 41%, and 11%, respectively).<xref ref-type="bibr" rid="article-24969.r10">[10]</xref></p>
        <p>On physical examination, signs of meningeal irritation can be present - nuchal rigidity, Kernig's and Brudzinski's signs. Those signs have high specificity in patients with meningitis. However, their sensitivity is low. In a study conducted by Thomas et al. that analyzed adults with meningitis suspicion, researchers reported the specificity of 95% and sensitivity of 5% for both Kernig's and Brudzinski's signs and a sensitivity of 30% and specificity of 68% for nuchal rigidity.<xref ref-type="bibr" rid="article-24969.r11">[11]</xref> Altered mental status is observable &#x02013; confusion, decreased alertness, or even seizures.</p>
        <p>
<bold>Children</bold>
</p>
        <p>Clinical signs of neonatal and infant meningitis are usually non-specific, including irritability or lethargy, fever or hypothermia, poor feeding, and vomiting with diarrhea. More specific signs on the physical examination like bulging fontanel, nuchal rigidity, and seizures in neonates are usually late findings.<xref ref-type="bibr" rid="article-24969.r12">[12]</xref> In the study of Amarilyo et al., half of the enrolled patients with meningitis with open fontanel had bulging fontanel.<xref ref-type="bibr" rid="article-24969.r13">[13]</xref> This study enrolled children aged two months to 16 years with suspected meningitis - Kernig's and Brudzinski's signs had a sensitivity of 27% and 51%, respectively, with a high positive predictive value of 77% and 81%, respectively. Classic meningeal signs are often absent in infants less than six months. Weber et al. proved that reduced feeding, the appearance of being very sick, being lethargic or unconscious, neck stiffness, and a bulging fontanel are the variables associated independently with meningitis in children aged two months to 3 years.<xref ref-type="bibr" rid="article-24969.r14">[14]</xref></p>
      </sec>
      <sec id="article-24969.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>The pivotal test for the diagnosis of meningitis (including streptococcal) is cerebrospinal fluid (CSF) examination. It is required to confirm the diagnosis, identify the causative bacterial pathogen, and, therefore, to implement de-escalated treatment later on. CSF should be obtained as soon as bacterial meningitis is suspected unless contraindications for urgent lumbar puncture (LP) are present. Contraindications for immediate LP include risk of herniation, uncorrected coagulopathy, or critical condition of the patient. According to the Infectious Diseases Society of America guidelines, head CT before LP is warranted in the case of focal neurologic deficit, abnormal level of consciousness, papilledema, seizure within one week of presentation, history of central nervous system disease, and an immunocompromised state. During LP, samples of CSF are taken and sent for physical and chemical characteristics, cell count, Gram stain, latex agglutination test (LAT), culture, and, if available, polymerase chain reaction (PCR). CSF examination in patients with streptococcal meningitis usually shows neutrophilic pleocytosis (white blood count of 500/ microL or higher), elevated lactate level, and lowered CSF/serum glucose ratio. CSF leukocyte count less than 50/mm^3 and elevated CSF protein level (at least 660 mg/dL) were poor prognostic factors in children with pneumococcal meningitis.<xref ref-type="bibr" rid="article-24969.r15">[15]</xref> CSF Gram staining results in the initial identification of bacteria. LAT detects antigens of few pathogens, among them S. pneumoniae. Results are provided in a short time. The causative pathogen is confirmed by positive culture from the CSF sample; however, in a study comparing traditional culture and antigen detection methods, less than half of the cases of bacterial meningitis were culture positive.<xref ref-type="bibr" rid="article-24969.r16">[16]</xref> Another option was PCR, especially valid when previously using antibiotics. The use of the PCR test in determining the etiology of bacterial meningitis is increasing. However, it recognizes only several types of bacteria &#x02013; the ones included in the primer mix. In the previously mentioned study, LAT proved to be more sensitive compared to conventional Gram stain and culture technique in identifying the specific organisms like <italic toggle="yes">H. influenzae</italic>, <italic toggle="yes">S. pneumoniae</italic>, and Group B <italic toggle="yes">Streptococcus</italic>. Nevertheless, the combination of culture, Gram stain, and LAT was more effective than any single method alone.<xref ref-type="bibr" rid="article-24969.r16">[16]</xref></p>
        <p>Other laboratory tests include blood culture &#x02013; necessary to take to increase the likelihood of identification of causative pathogen - as well as complete blood count, inflammatory markers (often much elevated), coagulation testing, markers of liver and kidney function. There should be no delays in instituting treatment because of all the diagnostic procedures.</p>
      </sec>
      <sec id="article-24969.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Streptococcal meningitis requires immediate treatment with antibiotics. Delays in implementing treatment are not acceptable.</p>
        <p>
<bold>S. <italic toggle="yes">pneumoniae</italic></bold>
</p>
        <p>Initial treatment for pneumococcal meningitis consists of vancomycin plus one of the third-generation cephalosporins: cefotaxime or ceftriaxone. The antibiotic therapy can undergo review after antibiotic sensitivity is available &#x02013; if bacteria is penicillin-susceptible, switch to penicillin is acceptable. For patients with a history of anaphylaxis to cephalosporins or penicillins, chloramphenicol is an option. Adjuvant therapy with dexamethasone is recommended - research showed a significant reduction in mortality and all unfavorable outcomes in patients with pneumococcal meningitis compared to sole antibiotic treatment.<xref ref-type="bibr" rid="article-24969.r17">[17]</xref><xref ref-type="bibr" rid="article-24969.r18">[18]</xref></p>
        <p>
<bold>S. <italic toggle="yes">agalactiae</italic></bold>
</p>
        <p>Penicillin G monotherapy is suitable for the treatment of meningitis caused by GBS. Ampicillin is an acceptable alternative.</p>
        <p>
<bold>
<italic toggle="yes">S. viridans, Group A Streptococcus</italic>
</bold>
</p>
        <p>Penicillin G is effective for the treatment of meningitis caused by <italic toggle="yes">S. viridans</italic> or group A <italic toggle="yes">Streptococcus</italic>.</p>
        <p>Supportive care, including fluid management, reduction of intracranial pressure, antipyretics, and analgesics, are valid parts of the therapy.</p>
      </sec>
      <sec id="article-24969.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Diseases that merit consideration in the differential diagnosis are other neural infections. Meningitis of different bacterial etiology (i.e., meningococcal) can be mistaken for streptococcal meningitis. It is impossible to establish the etiology taking into consideration only the clinical picture. CSF culture is indispensable in making a precise diagnosis. Viral and fungal etiologies of meningitis must also be ruled out. Encephalitis is another disease that can present itself very similarly to meningitis. Although encephalitis can affect meninges as well, evidence of brain inflammation is the distinguishing feature absent in meningitis. All other causes of altered mental status and coma should be ruled out, including stroke, intoxication, hypoglycemia, and electrolyte disturbances.</p>
        <list list-type="bullet">
          <list-item>
            <p>Brain abscess</p>
          </list-item>
          <list-item>
            <p>Brain tumors</p>
          </list-item>
          <list-item>
            <p>Subdural/epidural abscess</p>
          </list-item>
          <list-item>
            <p>Central nervous system (CNS) leukemia</p>
          </list-item>
          <list-item>
            <p>Hypersensitivity to drugs</p>
          </list-item>
          <list-item>
            <p>CNS tuberculosis</p>
          </list-item>
          <list-item>
            <p>Disorders associated with vasculitis (e.g., Kawasaki disease and collagen vascular disease)</p>
          </list-item>
          <list-item>
            <p>Lead encephalopathy</p>
          </list-item>
          <list-item>
            <p>Encephalitis</p>
          </list-item>
          <list-item>
            <p>Cerebrovascular accident</p>
          </list-item>
          <list-item>
            <p>Hypoglycemia</p>
          </list-item>
          <list-item>
            <p>Intoxication</p>
          </list-item>
          <list-item>
            <p>Viral meningitis</p>
          </list-item>
          <list-item>
            <p>Fungal meningitis</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-24969.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Prognosis in streptococcal meningitis is always serious. In a Danish study of pneumococcal meningitis, the overall case-fatality rate was 21%, with a 10-fold higher mortality rate in adults than in children.<xref ref-type="bibr" rid="article-24969.r10">[10]</xref> The causes of death were neurological, such as brain herniation, cerebrovascular complications (41% of the patients), systemic causes like septic shock, multiple-organ dysfunction (nearly one-fourth), other causes (8%), and roughly one-third died due to a combination of systemic and neurological complications.<xref ref-type="bibr" rid="article-24969.r10">[10]</xref> Advanced age, presence of lung focus, convulsions, having a CT scan before lumbar puncture, and need for assisted ventilation were prognostic factors associated with a fatal outcome within 100 days. The otogenic focus was associated with better survival.<xref ref-type="bibr" rid="article-24969.r10">[10]</xref> Retrospective analysis showed that the initial presentation of coma, respiratory failure, shock, and leukopenia (WBC less than 4,000/mm^3) were poor prognostic factors in children with meningitis.<xref ref-type="bibr" rid="article-24969.r15">[15]</xref> Mortality rates for GBS meningitis in neonates decreased following the introduction of intrapartum chemoprophylaxis. However, it remains high (11.4% among 848 patients enrolled).<xref ref-type="bibr" rid="article-24969.r19">[19]</xref> Neurological and systemic sequelae in survivors are common.</p>
      </sec>
      <sec id="article-24969.s11" sec-type="Complications">
        <title>Complications</title>
        <p>The incidence of neurological sequelae in survivors of pneumococcal meningitis remains high. Kastenbauer et al., in their study of adults, showed that meningitis-associated intracranial complications concerned 74.7% of the patients after pneumococcal meningitis and systemic complications touched over one-third of the patients. Some of the complications were seizure (27.6%), diffuse brain swelling (28.7%), hearing loss (19.7%), ischemic or hemorrhagic brain damage (21.8%), and hydrocephalus (16.1%).<xref ref-type="bibr" rid="article-24969.r20">[20]</xref> In Van De Beek's study, researchers found focal neurological deficits in 65% of the patients with pneumococcal meningitis, with the most common one being hearing impairment.<xref ref-type="bibr" rid="article-24969.r8">[8]</xref></p>
        <p>In children, the developmental delay was the most common long-term post-pneumococcal meningitis sequelae concerning 43% of the enrolled children.<xref ref-type="bibr" rid="article-24969.r21">[21]</xref> In almost one-third of survivors, seizures were observed at one year postinfection. Hearing loss occurred in 29% of the children.</p>
        <p>Long-term morbidity in survivors of GBS meningitis is significant. One-fourth of the children with GBS meningitis had a mild-to-moderate impairment; almost 20% showed severe impairment when assessed later.<xref ref-type="bibr" rid="article-24969.r22">[22]</xref></p>
      </sec>
      <sec id="article-24969.s12" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Patient education about Streptococcal meningitis, including alarming symptoms, is vital to provide the best possible outcome. Treatment delay is an unfavorable factor in bacterial meningitis. Pregnant women should be informed by their obstetrician about possible intrapartum chemoprophylaxis.</p>
      </sec>
      <sec id="article-24969.s13" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>
<bold>Transmission</bold>
</p>
        <p><italic toggle="yes">S. pneumoniae</italic> spreads through respiratory droplets from people with Pneumococcal disease or healthy carriers with the bacteria in their nasopharynx. However, there is a little chance of having pneumococcal meningitis even after close contact. There are individual factors that make the person vulnerable to the development of pneumococcal meningitis, including immunocompromised, especially patients with asplenia, diabetes, leak of cerebrospinal fluid, cochlear implant, history of meningitis, cigarette smoking, and alcohol use.</p>
        <p>GBS is a common finding in gastrointestinal and genital tracts. Women who become colonized with this bacteria can pass it on to their newborns during labor. In adults, most of the GBS meningitis is found in patients with comorbid conditions.</p>
        <p>
<bold>Prevention</bold>
</p>
        <p>Among all streptococcal meningitides, only pneumococcal is a vaccine-preventable condition. Two types of vaccines exist against <italic toggle="yes">Streptococcus pneumoniae</italic>: older pneumococcal polysaccharide vaccine (PPSV) and newer pneumococcal conjugate vaccines (PCV). PPSV is composed of 23 pneumococcal capsular polysaccharides, and it covers the broadest range of antigens out of all pneumococcal vaccines. Children less than two years old do not respond to this vaccination, though it is suitable only for patients&#x000a0;over two years of age. In the meta-analysis by Falkenhorst et al., PPSV23 efficacy against IPD caused by any serotype was reported to be 73% in a pooled analysis of all included clinical trials enrolling adults aged above 60 years living in industrialized countries.<xref ref-type="bibr" rid="article-24969.r23">[23]</xref> PCV contains pneumococcal capsular polysaccharides linked to a carrier protein that allows the immune system of infants to produce antibodies. The recommendation is to use PCV in the children's routine immunizations. There are two types of PCV available with a different number of serotypes: PCV10 and PCV13. Lucero et al. conducted a meta-analysis of six randomized trials of different valencies of PCV. In children of less than two years of age, the efficacy of PCV for preventing vaccine-type IPD was 80%, and 58% for preventing IPD caused by all serotypes.<xref ref-type="bibr" rid="article-24969.r24">[24]</xref> The CAPiTA trial assessed the efficacy of PCV13 with immunocompetent adults above 65 years of age enrolled. Results demonstrated about 75% efficacy against the vaccine-type invasive pneumococcal disease.<xref ref-type="bibr" rid="article-24969.r25">[25]</xref></p>
        <p>Meningitis caused by group B streptococci is also preventable by testing all pregnant women at 35&#x000a0;to 37 weeks of gestation for vagina and rectum colonization with GBS and using antibiotic chemoprophylaxis in colonized women. Approximately half of the colonized women will pass the bacteria to their neonates during labor or after membranes rupture. If not for intrapartum antibiotic prophylaxis, up to 2% of those newborns will develop GBS EOD.<xref ref-type="bibr" rid="article-24969.r26">[26]</xref> Since the implementation of national guidelines in the USA for intrapartum prophylaxis, statistics show a reduction in the occurrence of GBS EOD of more than 80% between the early 1990s and 2010.<xref ref-type="bibr" rid="article-24969.r27">[27]</xref></p>
      </sec>
      <sec id="article-24969.s14" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Streptococcal meningitis is a severe, life-threatening infection. It may pose a diagnostic challenge, especially in infants, because these patients may exhibit non-specific signs. The most vital for a patient outcome is fast diagnosis and treatment. Doctors who work in primary care facilities should educate their patients about alarming symptoms of meningitis. While the pediatrician or internist is almost always involved in the care of patients with streptococcal meningitis, it is essential to cooperate with other specialists that include infectious disease experts or anesthesiologists if needed. The nurses are also vital members of the interprofessional group, as they will monitor the patient's vital signs. Laboratory professionals play an essential role in establishing the diagnosis of causative agents. A physiotherapist is also needed to reduce the neurological burden of streptococcal meningitis. A board-certified infectious disease pharmacist can review antibiotic choices with the clinician, using the latest antibiogram data. They can also check for interactions, verify dosing and duration, and communicate with the rest of the team regarding potential adverse events. Interprofessional team efforts are necessary to improve outcomes for patients. [Level 5]</p>
      </sec>
      <sec id="article-24969.s15">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=24969&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=24969">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/infectious-disease/streptococcal-meningitis/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=24969">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/24969/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=24969">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-24969.s16">
        <title>References</title>
        <ref id="article-24969.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Castelblanco</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hasbun</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Epidemiology of bacterial meningitis in the USA from 1997 to 2010: a population-based observational study.</article-title>
            <source>Lancet Infect Dis</source>
            <year>2014</year>
            <month>Sep</month>
            <volume>14</volume>
            <issue>9</issue>
            <fpage>813</fpage>
            <page-range>813-9</page-range>
            <pub-id pub-id-type="pmid">25104307</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24969.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Oordt-Speets</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Bolijn</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>van Hoorn</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>Bhavsar</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kyaw</surname>
                <given-names>MH</given-names>
              </name>
            </person-group>
            <article-title>Global etiology of bacterial meningitis: A systematic review and meta-analysis.</article-title>
            <source>PLoS One</source>
            <year>2018</year>
            <volume>13</volume>
            <issue>6</issue>
            <fpage>e0198772</fpage>
            <pub-id pub-id-type="pmid">29889859</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24969.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Brouwer</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Tunkel</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>van de Beek</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Epidemiology, diagnosis, and antimicrobial treatment of acute bacterial meningitis.</article-title>
            <source>Clin Microbiol Rev</source>
            <year>2010</year>
            <month>Jul</month>
            <volume>23</volume>
            <issue>3</issue>
            <fpage>467</fpage>
            <page-range>467-92</page-range>
            <pub-id pub-id-type="pmid">20610819</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24969.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nanduri</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Petit</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Smelser</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Apostol</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Alden</surname>
                <given-names>NB</given-names>
              </name>
              <name>
                <surname>Harrison</surname>
                <given-names>LH</given-names>
              </name>
              <name>
                <surname>Lynfield</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Vagnone</surname>
                <given-names>PS</given-names>
              </name>
              <name>
                <surname>Burzlaff</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Spina</surname>
                <given-names>NL</given-names>
              </name>
              <name>
                <surname>Dufort</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>Schaffner</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Thomas</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Farley</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Jain</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Pondo</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>McGee</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Beall</surname>
                <given-names>BW</given-names>
              </name>
              <name>
                <surname>Schrag</surname>
                <given-names>SJ</given-names>
              </name>
            </person-group>
            <article-title>Epidemiology of Invasive Early-Onset and Late-Onset Group B Streptococcal Disease in the United States, 2006 to 2015: Multistate Laboratory and Population-Based Surveillance.</article-title>
            <source>JAMA Pediatr</source>
            <year>2019</year>
            <month>Mar</month>
            <day>01</day>
            <volume>173</volume>
            <issue>3</issue>
            <fpage>224</fpage>
            <page-range>224-233</page-range>
            <pub-id pub-id-type="pmid">30640366</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24969.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Madrid</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Seale</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Kohli-Lynch</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Edmond</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Lawn</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Heath</surname>
                <given-names>PT</given-names>
              </name>
              <name>
                <surname>Madhi</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Baker</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Bartlett</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Cutland</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Gravett</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Ip</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Le Doare</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Rubens</surname>
                <given-names>CE</given-names>
              </name>
              <name>
                <surname>Saha</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Sobanjo-Ter Meulen</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Vekemans</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Schrag</surname>
                <given-names>S</given-names>
              </name>
              <collab>Infant GBS Disease Investigator Group</collab>
            </person-group>
            <article-title>Infant Group B Streptococcal Disease Incidence and Serotypes Worldwide: Systematic Review and Meta-analyses.</article-title>
            <source>Clin Infect Dis</source>
            <year>2017</year>
            <month>Nov</month>
            <day>06</day>
            <volume>65</volume>
            <issue>suppl_2</issue>
            <fpage>S160</fpage>
            <page-range>S160-S172</page-range>
            <pub-id pub-id-type="pmid">29117326</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24969.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Birlutiu</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Birlutiu</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Costache</surname>
                <given-names>VS</given-names>
              </name>
            </person-group>
            <article-title>Viridans streptococcal infective endocarditis associated with fixed orthodontic appliance managed surgically by mitral valve plasty: A case report.</article-title>
            <source>Medicine (Baltimore)</source>
            <year>2018</year>
            <month>Jul</month>
            <volume>97</volume>
            <issue>27</issue>
            <fpage>e11260</fpage>
            <pub-id pub-id-type="pmid">29979391</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24969.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lucas</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Brouwer</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Bovenkerk</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Man</surname>
                <given-names>WK</given-names>
              </name>
              <name>
                <surname>van der Ende</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>van de Beek</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Group A Streptococcal meningitis in adults.</article-title>
            <source>J Infect</source>
            <year>2015</year>
            <month>Jul</month>
            <volume>71</volume>
            <issue>1</issue>
            <fpage>37</fpage>
            <page-range>37-42</page-range>
            <pub-id pub-id-type="pmid">25614959</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24969.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>van de Beek</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>de Gans</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Spanjaard</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Weisfelt</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Reitsma</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Vermeulen</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Clinical features and prognostic factors in adults with bacterial meningitis.</article-title>
            <source>N Engl J Med</source>
            <year>2004</year>
            <month>Oct</month>
            <day>28</day>
            <volume>351</volume>
            <issue>18</issue>
            <fpage>1849</fpage>
            <page-range>1849-59</page-range>
            <pub-id pub-id-type="pmid">15509818</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24969.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lucht</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>[Sensitivity and specificity of clinical signs in adults].</article-title>
            <source>Med Mal Infect</source>
            <year>2009</year>
            <season>Jul-Aug</season>
            <volume>39</volume>
            <issue>7-8</issue>
            <fpage>445</fpage>
            <page-range>445-51</page-range>
            <pub-id pub-id-type="pmid">19632074</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24969.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>&#x000d8;stergaard</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Konradsen</surname>
                <given-names>HB</given-names>
              </name>
              <name>
                <surname>Samuelsson</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Clinical presentation and prognostic factors of Streptococcus pneumoniae meningitis according to the focus of infection.</article-title>
            <source>BMC Infect Dis</source>
            <year>2005</year>
            <month>Oct</month>
            <day>27</day>
            <volume>5</volume>
            <fpage>93</fpage>
            <pub-id pub-id-type="pmid">16253143</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24969.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Thomas</surname>
                <given-names>KE</given-names>
              </name>
              <name>
                <surname>Hasbun</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Jekel</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Quagliarello</surname>
                <given-names>VJ</given-names>
              </name>
            </person-group>
            <article-title>The diagnostic accuracy of Kernig's sign, Brudzinski's sign, and nuchal rigidity in adults with suspected meningitis.</article-title>
            <source>Clin Infect Dis</source>
            <year>2002</year>
            <month>Jul</month>
            <day>01</day>
            <volume>35</volume>
            <issue>1</issue>
            <fpage>46</fpage>
            <page-range>46-52</page-range>
            <pub-id pub-id-type="pmid">12060874</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24969.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ku</surname>
                <given-names>LC</given-names>
              </name>
              <name>
                <surname>Boggess</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Cohen-Wolkowiez</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Bacterial meningitis in infants.</article-title>
            <source>Clin Perinatol</source>
            <year>2015</year>
            <month>Mar</month>
            <volume>42</volume>
            <issue>1</issue>
            <fpage>29</fpage>
            <page-range>29-45, vii-viii</page-range>
            <pub-id pub-id-type="pmid">25677995</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24969.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Amarilyo</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Alper</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ben-Tov</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Grisaru-Soen</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Diagnostic accuracy of clinical symptoms and signs in children with meningitis.</article-title>
            <source>Pediatr Emerg Care</source>
            <year>2011</year>
            <month>Mar</month>
            <volume>27</volume>
            <issue>3</issue>
            <fpage>196</fpage>
            <page-range>196-9</page-range>
            <pub-id pub-id-type="pmid">21346676</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24969.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Weber</surname>
                <given-names>MW</given-names>
              </name>
              <name>
                <surname>Herman</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Jaffar</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Usen</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Oparaugo</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Omosigho</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Adegbola</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Greenwood</surname>
                <given-names>BM</given-names>
              </name>
              <name>
                <surname>Mulholland</surname>
                <given-names>EK</given-names>
              </name>
            </person-group>
            <article-title>Clinical predictors of bacterial meningitis in infants and young children in The Gambia.</article-title>
            <source>Trop Med Int Health</source>
            <year>2002</year>
            <month>Sep</month>
            <volume>7</volume>
            <issue>9</issue>
            <fpage>722</fpage>
            <page-range>722-31</page-range>
            <pub-id pub-id-type="pmid">12225501</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24969.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ma</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>PY</given-names>
              </name>
              <name>
                <surname>Mak</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Chi</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Lau</surname>
                <given-names>YJ</given-names>
              </name>
            </person-group>
            <article-title>Clinical outcome of invasive pneumococcal infection in children: a 10-year retrospective analysis.</article-title>
            <source>J Microbiol Immunol Infect</source>
            <year>2002</year>
            <month>Mar</month>
            <volume>35</volume>
            <issue>1</issue>
            <fpage>23</fpage>
            <page-range>23-8</page-range>
            <pub-id pub-id-type="pmid">11950116</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24969.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mohammadi</surname>
                <given-names>SF</given-names>
              </name>
              <name>
                <surname>Patil</surname>
                <given-names>AB</given-names>
              </name>
              <name>
                <surname>Nadagir</surname>
                <given-names>SD</given-names>
              </name>
              <name>
                <surname>Nandihal</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Lakshminarayana</surname>
                <given-names>SA</given-names>
              </name>
            </person-group>
            <article-title>Diagnostic value of latex agglutination test in diagnosis of acute bacterial meningitis.</article-title>
            <source>Ann Indian Acad Neurol</source>
            <year>2013</year>
            <month>Oct</month>
            <volume>16</volume>
            <issue>4</issue>
            <fpage>645</fpage>
            <page-range>645-9</page-range>
            <pub-id pub-id-type="pmid">24339598</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24969.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Brouwer</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Heckenberg</surname>
                <given-names>SG</given-names>
              </name>
              <name>
                <surname>de Gans</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Spanjaard</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Reitsma</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>van de Beek</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Nationwide implementation of adjunctive dexamethasone therapy for pneumococcal meningitis.</article-title>
            <source>Neurology</source>
            <year>2010</year>
            <month>Oct</month>
            <day>26</day>
            <volume>75</volume>
            <issue>17</issue>
            <fpage>1533</fpage>
            <page-range>1533-9</page-range>
            <pub-id pub-id-type="pmid">20881273</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24969.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>de Gans</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>van de Beek</surname>
                <given-names>D</given-names>
              </name>
              <collab>European Dexamethasone in Adulthood Bacterial Meningitis Study Investigators</collab>
            </person-group>
            <article-title>Dexamethasone in adults with bacterial meningitis.</article-title>
            <source>N Engl J Med</source>
            <year>2002</year>
            <month>Nov</month>
            <day>14</day>
            <volume>347</volume>
            <issue>20</issue>
            <fpage>1549</fpage>
            <page-range>1549-56</page-range>
            <pub-id pub-id-type="pmid">12432041</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24969.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Romain</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Cohen</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Plainvert</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Joubrel</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>B&#x000e9;chet</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Perret</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Tazi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Poyart</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Levy</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Clinical and Laboratory Features of Group B Streptococcus Meningitis in Infants and Newborns: Study of 848 Cases in France, 2001-2014.</article-title>
            <source>Clin Infect Dis</source>
            <year>2018</year>
            <month>Mar</month>
            <day>05</day>
            <volume>66</volume>
            <issue>6</issue>
            <fpage>857</fpage>
            <page-range>857-864</page-range>
            <pub-id pub-id-type="pmid">29045606</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24969.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kastenbauer</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Pfister</surname>
                <given-names>HW</given-names>
              </name>
            </person-group>
            <article-title>Pneumococcal meningitis in adults: spectrum of complications and prognostic factors in a series of 87 cases.</article-title>
            <source>Brain</source>
            <year>2003</year>
            <month>May</month>
            <volume>126</volume>
            <issue>Pt 5</issue>
            <fpage>1015</fpage>
            <page-range>1015-25</page-range>
            <pub-id pub-id-type="pmid">12690042</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24969.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Stockmann</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Ampofo</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Byington</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>Filloux</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Hersh</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Blaschke</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Cowan</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Korgenski</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Mason</surname>
                <given-names>EO</given-names>
              </name>
              <name>
                <surname>Pavia</surname>
                <given-names>AT</given-names>
              </name>
            </person-group>
            <article-title>Pneumococcal meningitis in children: epidemiology, serotypes, and outcomes from 1997-2010 in Utah.</article-title>
            <source>Pediatrics</source>
            <year>2013</year>
            <month>Sep</month>
            <volume>132</volume>
            <issue>3</issue>
            <fpage>421</fpage>
            <page-range>421-8</page-range>
            <pub-id pub-id-type="pmid">23979090</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24969.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Libster</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Edwards</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Levent</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Edwards</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Rench</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Castagnini</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Cooper</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Sparks</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>Baker</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Shah</surname>
                <given-names>PE</given-names>
              </name>
            </person-group>
            <article-title>Long-term outcomes of group B streptococcal meningitis.</article-title>
            <source>Pediatrics</source>
            <year>2012</year>
            <month>Jul</month>
            <volume>130</volume>
            <issue>1</issue>
            <fpage>e8</fpage>
            <page-range>e8-15</page-range>
            <pub-id pub-id-type="pmid">22689869</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24969.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Falkenhorst</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Remschmidt</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Harder</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Hummers-Pradier</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Wichmann</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Bogdan</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Effectiveness of the 23-Valent Pneumococcal Polysaccharide Vaccine (PPV23) against Pneumococcal Disease in the Elderly: Systematic Review and Meta-Analysis.</article-title>
            <source>PLoS One</source>
            <year>2017</year>
            <volume>12</volume>
            <issue>1</issue>
            <fpage>e0169368</fpage>
            <pub-id pub-id-type="pmid">28061505</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24969.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lucero</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Dulalia</surname>
                <given-names>VE</given-names>
              </name>
              <name>
                <surname>Nillos</surname>
                <given-names>LT</given-names>
              </name>
              <name>
                <surname>Williams</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Parre&#x000f1;o</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Nohynek</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Riley</surname>
                <given-names>ID</given-names>
              </name>
              <name>
                <surname>Makela</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Pneumococcal conjugate vaccines for preventing vaccine-type invasive pneumococcal disease and X-ray defined pneumonia in children less than two years of age.</article-title>
            <source>Cochrane Database Syst Rev</source>
            <year>2009</year>
            <month>Oct</month>
            <day>07</day>
            <volume>2009</volume>
            <issue>4</issue>
            <fpage>CD004977</fpage>
            <pub-id pub-id-type="pmid">19821336</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24969.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bonten</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Huijts</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Bolkenbaas</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Webber</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Patterson</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Gault</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>van Werkhoven</surname>
                <given-names>CH</given-names>
              </name>
              <name>
                <surname>van Deursen</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Sanders</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>Verheij</surname>
                <given-names>TJ</given-names>
              </name>
              <name>
                <surname>Patton</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>McDonough</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Moradoghli-Haftvani</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Mellelieu</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Pride</surname>
                <given-names>MW</given-names>
              </name>
              <name>
                <surname>Crowther</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Schmoele-Thoma</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Scott</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Jansen</surname>
                <given-names>KU</given-names>
              </name>
              <name>
                <surname>Lobatto</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Oosterman</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Visser</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Caspers</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Smorenburg</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Emini</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>Gruber</surname>
                <given-names>WC</given-names>
              </name>
              <name>
                <surname>Grobbee</surname>
                <given-names>DE</given-names>
              </name>
            </person-group>
            <article-title>Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults.</article-title>
            <source>N Engl J Med</source>
            <year>2015</year>
            <month>Mar</month>
            <day>19</day>
            <volume>372</volume>
            <issue>12</issue>
            <fpage>1114</fpage>
            <page-range>1114-25</page-range>
            <pub-id pub-id-type="pmid">25785969</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24969.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <article-title>Prevention of Group B Streptococcal Early-Onset Disease in Newborns: ACOG Committee Opinion, Number 782.</article-title>
            <source>Obstet Gynecol</source>
            <year>2019</year>
            <month>Jul</month>
            <volume>134</volume>
            <issue>1</issue>
            <fpage>1</fpage>
            <pub-id pub-id-type="pmid">31241599</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24969.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schrag</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Verani</surname>
                <given-names>JR</given-names>
              </name>
            </person-group>
            <article-title>Intrapartum antibiotic prophylaxis for the prevention of perinatal group B streptococcal disease: experience in the United States and implications for a potential group B streptococcal vaccine.</article-title>
            <source>Vaccine</source>
            <year>2013</year>
            <month>Aug</month>
            <day>28</day>
            <volume>31 Suppl 4</volume>
            <fpage>D20</fpage>
            <page-range>D20-6</page-range>
            <pub-id pub-id-type="pmid">23219695</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
